FDA awards 12 grants to fund new clinical trials to advance development of medical products for treatment of rare diseases
The US Food and Drug Administration (FDA) has announced that it has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of medical products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry across the country.“…This funding helps support early-stage development activities targeting rare diseases that don’t have effective treatments
To continue reading this article
Continue reading your article with a eMediNexus account.